Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Women with OAB symptoms including urgency, frequency (voids ≥8/day), and urge incontinence~2. Women who consume \> one cup (250ml) caffeinated beverage per day~3. Women who score $ 6 on the QUID Questionnaire for urgency symptoms~Exclusion Criteria:~1. Women currently receiving treatment for OAB symptoms~2. Women with narrow angle Glaucoma~3. Women taking anticholinergics or loop diuretics~4. Women with an untreated urinary tract infection. After resolution of the UTI, and if all other eligibility criteria are met, the woman can be a candidate for inclusion in the study.~5. Women with a diagnosis of painful bladder syndrome or other abnormal urinary tract lesions~6. Women scoring \>4 on the QUID Questionnaire for stress symptoms~7. Women with de novo symptoms following surgery~8. Women with major pelvic prolapse

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Caffeine reduction through diet and beverage counselling
- 2 (Type: ACTIVE_COMPARATOR): Anticholinergic medication

Based on this trial design, predict the completion outcome and termination type (if applicable).